We next tested whether CCL2 directly induces phosphorylation of paxillin and treated SU.86.86 and T3M4 pancreatic cancer cells with 100 ng/mL of rCCL2 for 5, 15, and 25 minutes. This evidence concerns the gene CCL2 and familial pancreatic carcinoma.